"From the Frontlines" is an ADL podcast which brings listeners to the frontline in the battle against antisemitism and hate.
In this battle, our corporate boardrooms have become yet another playing field. Enter JLens, an affiliate of ADL, and a Registered Investment Adviser whose mission is to empower investors to align their capital with Jewish values and to advocate for Jewish communal priorities in the corporate arena. JLens is not new. It has been around for more than a dozen years, and several shows have been devoted to their work. What is new is TOV, as in the Hebrew word for “good”. This is an ETF or exchange traded fund which allows for investors to have a new financial tool to fight antisemitism and hate. TOV launched a few weeks ago with $100 million in seed capital. But what does this all mean and how does this fund actually fight antisemitism? These questions and more are answered by Ari Hoffnung. He is the Managing Director of JLens and is the guest for this "From the Frontlines" podcast.
For more information on TOV, visit https://investjewishly.org/.
JLens is a Registered Investment Advisor with the Securities and Exchange Commission (SEC) and an ADL affiliate. Registration does not imply any specific level of skill or training. This podcast is for informational purposes only, and does not constitute investment advice. Listeners should consult their own financial advisor to determine the appropriateness of any investment. Investments in ETFs are subject to risks, including the loss of principal. ETFs may not be suitable for all investors. Past performance is not indicative of future results. The performance of ETFs may vary due to market conditions and changes in holdings. The opinions expressed are those of the speakers and do not necessarily reflect the views of JLens or ADL. This podcast may include forward-looking statements which are inherently speculative. Actual results may vary. No endorsements are made for any specific securities, investment strategies, or financial services made in this episode.